BioMarin Pharmaceutical
BMRN
#1485
Rank
$11.34 B
Marketcap
$59.17
Share price
0.60%
Change (1 day)
-33.24%
Change (1 year)

Revenue for BioMarin Pharmaceutical (BMRN)

Revenue in 2024 (TTM): $2.85 Billion USD

According to BioMarin Pharmaceutical's latest financial reports the company's current revenue (TTM ) is $2.85 Billion USD. an increase over the revenue in the year 2023 that were of $2.41 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BioMarin Pharmaceutical from 1999 to 2024

20002005201020152020$0.5B$1B$1.5B$2B$2.5B$3Bcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 $2.85 B17.97%
2023 $2.41 B15.42%
2022 $2.09 B13.53%
2021 $1.84 B-0.76%
2020 $1.86 B9.18%
2019 $1.70 B14.27%
2018 $1.49 B13.52%
2017 $1.31 B17.62%
2016 $1.11 B25.5%
2015 $0.88 B18.54%
2014 $0.75 B36.88%
2013 $0.54 B9.54%
2012 $0.50 B13.45%
2011 $0.44 B17.3%
2010 $0.37 B15.9%
2009 $0.32 B9.5%
2008 $0.29 B143.86%
2007 $0.12 B44.38%
2006 $84.2 M228.05%
2005 $25.66 M
2002 $13.91 M34.65%
2001 $10.33 M-16.14%
2000 $12.32 M76.59%
1999 $6.98 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$0.56 B-80.37%๐Ÿ‡บ๐Ÿ‡ธ USA
$57.8 M-97.97%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.33 B-88.36%๐Ÿ‡บ๐Ÿ‡ธ USA
$47.96 B 1,580.51%๐Ÿ‡ซ๐Ÿ‡ท France
$0.52 B-81.49%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.49 B-82.77%๐Ÿ‡บ๐Ÿ‡ธ USA